Amyris Inc
F:3A01
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amyris Inc
F:3A01
|
US |
|
H
|
Hanil Cement Co Ltd
KRX:300720
|
KR |
|
A
|
Al-Saif Stores for Development & Investment Company SJSC
SAU:4192
|
SA |
|
S
|
Shanghai Electric Group Co Ltd
XBER:USR
|
CN |
|
F
|
F-Code Inc
TSE:9211
|
JP |
|
A
|
Advanced Optoelectronic Technology Inc
TWSE:3437
|
TW |
|
Voya Financial Inc
NYSE:VOYA
|
US |
|
Nihon Parkerizing Co Ltd
TSE:4095
|
JP |
|
S
|
Shanghai Tianchen Co Ltd
SSE:600620
|
CN |
|
KEPCO Plant Service & Engineering Co Ltd
KRX:051600
|
KR |
|
Scala Inc
TSE:4845
|
JP |
|
S
|
Samyang Holdings Corp
KRX:000075
|
KR |
|
H
|
Hubei Mailyard Share Co Ltd
SSE:600107
|
CN |
|
Toho Gas Co Ltd
TSE:9533
|
JP |
|
Golden Eagle Retail Group Ltd
HKEX:3308
|
CN |
|
N
|
NTN Corp
TSE:6472
|
JP |
|
Gold Standard Ventures Corp
TSX:GSV
|
CA |
|
C
|
Carlyle Group Inc
F:3VU
|
US |
|
Karnalyte Resources Inc
TSX:KRN
|
CA |
|
Precipio Inc
NASDAQ:PRPO
|
US |
|
Digital Turbine Inc
NASDAQ:APPS
|
US |
|
Portmeirion Group PLC
LSE:PMP
|
UK |
|
Zheneng Jinjiang Environment Holding Co Ltd
SGX:BWM
|
CN |
|
P
|
Posbank Co Ltd
KOSDAQ:105760
|
KR |
Amyris Inc
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
